A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study from researchers at the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences.

News Medical

United States

Mouse protein disrupts cancer-causing epigenetic changes in human colorectal cancer

Medical Xpress

Scientists identify new epigenetic approach to target colorectal cancer

Ad Fontes Media

Media Bias/Fact Check

Ian Birkby

(Reuters) – The U.S. Food and Drug Administration approved Amgen’s combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation. Amgen’s Lumakras in combination with Vectibix was approved to treat adult patients whose cancer has spread to other parts of the body despite receiving chemotherapy, the health regulator said. The FDA also approved Netherlands-based Qiagen’s companion diagnostic device to identif…

All Sides

WTVB

Midwest Communications

US FDA approves Amgen’s colorectal cancer therapy

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study.

Science Daily

Daniel Hogan

The initiative offers free faecal occult blood tests (FOBT) to individuals over the age of 50. Prevention and early diagnosis are vital in combating this type of cancer. Aware of this, Quirónsalud Málaga Hospital has launched a free campaign aimed at the early detection and prevention of colorectal cancer. The initiative is targeted at individuals over 50 years old who do not present… Source

Euro Weekly News

Spain

Quirónsalud Málaga launches free campaign for colorectal cancer prevention and detection

Oxford Drug Design has reported positive results from an in vivo colorectal cancer model study on mice, which, it said, validated the firm's platform technology. The Oxford university spinout is discovering innovative anti-cancer therapeutics supported by pioneering artificial intelligence (AI) methods. READ MORE: Oxford Drug Design set to help advance new treatments for CF lung infections In a... Source

thebusinessmagazine.co.uk

Oxford Drug Design hails results of in vivo colorectal cancer study

The role of our 'second brain' in colorectal cancer 15 January 2025 joelle.vanwiss… Wed, 01/15/2025 - 11:29 
Science Stories
At the Faculty of Health, Medicine and Life Sciences, we conduct a lot of research. In our Science Stories, our researchers explain their work and the tools they use to perform their research for FHML. 
There are millions of nerve cells in our intestines, which are often referred to as our 'second brain'. These cells regul…

maastrichtuniversity.nl

The role of our 'second brain' in colorectal cancer

Epigenetic Research Offers Hope for Colorectal Cancer Treatment Recent findings from groundbreaking research conducted by experts from the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences illuminate a promising avenue for treating colorectal cancer and potentially other solid tumors. Central to this research is a relatively obscure protein found in mice, known as STELLA, which appears to disrupt harmful epigenetic alteratio…

BIOENGINEER.ORG

New Epigenetic Strategy Unveiled by Scientists to Combat Colorectal Cancer

Researchers at the Francis Crick Institute and Barts Cancer Institute, Queen Mary University of London, have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.

Mouse protein disrupts cancer-causing epigenetic changes in human colorectal cancer

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics